Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The headline numbers ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Shares of Gilead Sciences ( GILD 7.46%) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the big ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

The sector primarily comprises pharma/biotech and medical device companies. See the Zacks Earnings Calendar to stay ahead of market-making news. The earnings season for the medical sector kicked ...

Stock analysts at Zacks Small Cap raised their Q1 2025 earnings estimates for shares of Evaxion Biotech A/S in a research report issued to clients and investors on Thursday, February 6th. Zacks Small ...